ETHZilla

ETHZilla Equity

The The Equity of ETHZilla (ETHZ) as of Oct 17, 2026 is 239.42 B USD. In the previous year, The Equity was 9.25 M USD — a change of 2.59 M% (higher).

Equity

239.42 BUSD

YoY

2.59 M%

Last updated:

In 2025, ETHZilla's equity was 239.42 B USD, a 2.59 M% increase from the 9.25 M USD equity in the previous year.

The ETHZilla Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
113.87 M USD
Jan 1, 2019
38.57 M USD
Jan 1, 2020
30.29 M USD
Jan 1, 2021
39.32 M USD
Jan 1, 2022
11.34 M USD
Jan 1, 2023
-127,733.00 USD
Jan 1, 2024
9.25 M USD
Jan 1, 2025
239.42 B USD
The ETHZilla Equity history
YEAREquityYoY
239.42 BUSD+2.59 M%
9.25 MUSD-7,343.16%
-127,733.00USD-101.13%
11.34 MUSD-71.15%
39.32 MUSD+29.83%
30.29 MUSD-21.48%
38.57 MUSD-66.13%
113.87 MUSD+2,177.31%
5.00 MUSD+22,627.30%
22,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ETHZilla Stock analysis

What does ETHZilla do? ETHZilla Corp, based in New York City, operates in the Health Care sector within Biotechnology. The company develops pharmaceuticals for chronic pain and inflammatory diseases, focusing on three research programs: Fibrosis and Anti-TNF targeting conditions like Dupuytren’s contracture and NASH; SCAs addressing chronic pain and early arthritis; and a7nAChR for smoking cessation and ulcerative colitis. Listed on 27 June 2017, ETHZilla Corp employs four full-time staff. ETHZilla is one of the most popular companies on Eulerpool.

Equity Details

Analyzing ETHZilla's Equity

ETHZilla's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ETHZilla's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ETHZilla's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ETHZilla's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ETHZilla’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ETHZilla stock

The Equity of ETHZilla is 239.42 B USD in 2025.

The Equity of ETHZilla changed from 9.25 M USD to 239.42 B USD, representing a 2.59 M% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity ETHZilla since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's ETHZilla historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ETHZilla

All Key Metrics — ETHZilla